What is BioRestorative Therapies, Inc. Common Stock (NV)'s Market Cap?

BioRestorative Therapies, Inc. Common Stock (NV)'s Market Cap is $71.4M, based on as-reported figures from SEC (XBRL) filings.

What is BioRestorative Therapies, Inc. Common Stock (NV)'s Price / Sales?

BioRestorative Therapies, Inc. Common Stock (NV)'s Price / Sales is 199.5×, based on as-reported figures from SEC (XBRL) filings.

What is BioRestorative Therapies, Inc. Common Stock (NV)'s Revenue (TTM)?

BioRestorative Therapies, Inc. Common Stock (NV)'s Revenue (TTM) is $357.9K, based on as-reported figures from SEC (XBRL) filings.

What is BioRestorative Therapies, Inc. Common Stock (NV)'s Net Income (TTM)?

BioRestorative Therapies, Inc. Common Stock (NV)'s Net Income (TTM) is -$11.1M, based on as-reported figures from SEC (XBRL) filings.

What is BioRestorative Therapies, Inc. Common Stock (NV)'s Diluted EPS (TTM)?

BioRestorative Therapies, Inc. Common Stock (NV)'s Diluted EPS (TTM) is -0.43, based on as-reported figures from SEC (XBRL) filings.

What is BioRestorative Therapies, Inc. Common Stock (NV)'s EBITDA Margin?

BioRestorative Therapies, Inc. Common Stock (NV)'s EBITDA Margin is -3916.2%, based on as-reported figures from SEC (XBRL) filings.

BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) Financial Statements

BioRestorative Therapies, Inc. Common Stock (NV)

SIC 8090 · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC

FIGI BBG001S90FP6

XNAS · usd

2.80▲ 2.65 (1793.78%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close0.15

Day's Range2.70 – 3.23

52-Week Range0.14 – 3.23

Volume55.1K

Avg Volume399.8K

Share Statistics

Shares Outstanding

Employees14

ExchangeXNAS

Listed1997-12-22

Share count as of May 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about BioRestorative Therapies, Inc. Common Stock (NV) (BRTX)

What is BioRestorative Therapies, Inc. Common Stock (NV)'s Market Cap?: BioRestorative Therapies, Inc. Common Stock (NV)'s Market Cap is $71.4M, based on as-reported figures from SEC (XBRL) filings.
What is BioRestorative Therapies, Inc. Common Stock (NV)'s Price / Sales?: BioRestorative Therapies, Inc. Common Stock (NV)'s Price / Sales is 199.5×, based on as-reported figures from SEC (XBRL) filings.
What is BioRestorative Therapies, Inc. Common Stock (NV)'s Revenue (TTM)?: BioRestorative Therapies, Inc. Common Stock (NV)'s Revenue (TTM) is $357.9K, based on as-reported figures from SEC (XBRL) filings.
What is BioRestorative Therapies, Inc. Common Stock (NV)'s Net Income (TTM)?: BioRestorative Therapies, Inc. Common Stock (NV)'s Net Income (TTM) is -$11.1M, based on as-reported figures from SEC (XBRL) filings.
What is BioRestorative Therapies, Inc. Common Stock (NV)'s EBITDA?: BioRestorative Therapies, Inc. Common Stock (NV)'s EBITDA is -$14.0M, based on as-reported figures from SEC (XBRL) filings.
What is BioRestorative Therapies, Inc. Common Stock (NV)'s Diluted EPS (TTM)?: BioRestorative Therapies, Inc. Common Stock (NV)'s Diluted EPS (TTM) is -0.43, based on as-reported figures from SEC (XBRL) filings.
What is BioRestorative Therapies, Inc. Common Stock (NV)'s EBITDA Margin?: BioRestorative Therapies, Inc. Common Stock (NV)'s EBITDA Margin is -3916.2%, based on as-reported figures from SEC (XBRL) filings.